L
Luc Perrin
Researcher at Geneva College
Publications - 146
Citations - 13016
Luc Perrin is an academic researcher from Geneva College. The author has contributed to research in topics: Viral load & Virus. The author has an hindex of 57, co-authored 146 publications receiving 12771 citations. Previous affiliations of Luc Perrin include University of Geneva.
Papers
More filters
Journal ArticleDOI
Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts
TL;DR: It is demonstrated that APOBEC3G exerts its antiviral effect during reverse transcription to trigger G-to-Ahypermutation in the nascent retroviral DNA, suggesting that hypermutation by editing is a general innate defence mechanism against this important group of pathogens.
Journal ArticleDOI
Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study.
Gilbert Greub,Bruno Ledergerber,Manuel Battegay,P. J. Grob,Luc Perrin,Hansjakob Furrer,Philippe Bürgisser,Peter Erb,Katia Boggian,Jean-Claude Piffaretti,Bernard Hirschel,Pascal Janin,Patrick Francioli,Markus Flepp,Amalio Telenti +14 more
TL;DR: Hematitis C virus and active intravenous drug use could be important factors in the morbidity and mortality among HIV-1-infected patients, possibly through impaired CD4-cell recovery in HCV seropositive patients receiving potent antiretroviral therapy.
Journal ArticleDOI
Prevalence of Drug-Resistant HIV-1 Variants in Untreated Individuals in Europe: Implications for Clinical Management
Annemarie M. J. Wensing,David A. M. C. van de Vijver,Gioacchino Angarano,Birgitta Åsjö,Claudia Balotta,Enzo Boeri,Ricardo Jorge Camacho,Maire-Laure Chaix,Dominique Costagliola,Andrea De Luca,Inge Derdelinckx,Zehava Grossman,Osamah Hamouda,Angelos Hatzakis,Robert Hemmer,Andy I. M. Hoepelman,Andrzej Horban,Klaus Korn,Claudia Kücherer,Thomas Leitner,Clive Loveday,E MacRae,I Maljkovic,Carmen de Mendoza,Laurence Meyer,Claus J. Nielsen,Eline L. M. Op de Coul,Vidar Ormaasen,D Paraskevis,Luc Perrin,Elisabeth Puchhammer-Stöckl,Lidia Ruiz,Mika Salminen,Jean-Claude Schmit,François Schneider,Rob Schuurman,Vincent Soriano,G Stanczak,Maja Stanojevic,Anne-Mieke Vandamme,Kristel Van Laethem,Michela Violin,Karin Wilbe,Sabine Yerly,Maurizio Zazzi,Charles A. Boucher +45 more
TL;DR: In this paper, the authors determined the baseline rate of drug resistance in 2208 therapy-naive patients recently and chronically infected with HIV-1 from 19 European countries during 1996-2002.
Journal ArticleDOI
Transmission of antiretroviral-drug-resistant HIV-1 variants
TL;DR: The transmission of drug-resistant variants among individuals with primary HIV-1 infection is assessed and to introduce the best antiretroviral treatment, resistance testing should be done in recently HIV- 1-infected individuals.
CD4 T-Lymphocyte Recovery in Individuals With Advanced HIV-1 Infection Receiving Potent Antiretroviral Therapy for 4 Years
Gilbert R. Kaufmann,Luc Perrin,G. Pantaleo,Milos Opravil,Hansjakob Furrer,Amalio Telenti,Bernard Hirschel,Bruno Ledergerber,Pietro Vernazza,Enos Bernasconi,Martin Rickenbach,Matthias Egger,Manuel Battegay +12 more
TL;DR: In this article, a longitudinally analyzed study of 2235 participants of the Swiss HIV Cohort, commencing HAART between 1996 and 1997, showed that the CD4 Tlymphocyte count increase, the percentage of individuals with a CD4T-cell count of 500/μL or greater and less than 200μL, and the determinants of CD4-cell recovery were evaluated in individuals treated with continuous (CONT; n=985) and discontinuous (DISCONT, n=1250) HAART.